DuPont's stock, a component of the Dow industrials, was up 1.9% at $47.03 in afternoon trading after the company said it continues to expect revenue and earnings in its agriculture and nutrition unit to increase by more than 10% this financial year.
Despite this favorable outlook, Banc of America views the stock's current valuation as fair, and said the company faces other challenges.
"Favorable trends include robust agriculture markets, healthy demand overseas and cost cutting," the firm said. "However, we view valuation of 14.9 times our $3.17 [earnings estimate] for 2007 as fair given likely pressure on U.S. planted corn acreage in 2008, overweight auto exposure, cyclical pressure in U.S. construction, and a projected EPS hit of 41 cents a share in 2010 following pharma patent expirations for Cozaar/Hyzaar."
Banc of America's 12-month price target for DuPont is $48. Christie Rizk cr/tk1
COPYRIGHT
Copyright Thomson Financial News Limited 2007. All rights reserved. The copying, republication or redistribution of Thomson Financial News Content, including by framing or similar means, is expressly prohibited without the prior written consent of Thomson Financial News.
MMMM
More News:
Market Updates |
Stock Alerts |
All Trading News |
Stock Index